SGM:ASXSims Ltd. Analysis
Data as of 2026-06-21 - not real-time
A$29.20
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Sims Limited is trading firmly above its 20‑day and 50‑day moving averages (around 27.5 and 23.7 AUD) with a bullish MACD crossover and a rising volume trend, indicating short‑term momentum. However, the RSI is perched near 70, suggesting the stock may be edging into overbought territory and could face a near‑term pullback toward the identified support around 23.0 AUD. Fundamentally, the company posted a modest revenue growth of 3.5% but remains loss‑making with a negative profit margin and a free‑cash‑flow deficit, even though forward earnings estimates turn positive and the forward PE sits near 16. The dividend yield of just under 1% is supported by a low payout ratio, but sustainability is questionable given the current earnings profile. Analyst consensus is neutral with a “hold” rating and median target near 31 AUD, aligning the market price of 29.2 AUD close to fair value while the sector’s cyclical nature and high 30‑day volatility (~33%) add risk.
Overall, the stock presents a blend of value and growth characteristics: technical strength and modest upside potential are tempered by earnings volatility, debt levels, and sector‑specific regulatory pressures. Investors should monitor earnings releases for signs of a sustained turnaround and watch the price action around the key resistance level near 31.8 AUD before committing to larger positions.
Overall, the stock presents a blend of value and growth characteristics: technical strength and modest upside potential are tempered by earnings volatility, debt levels, and sector‑specific regulatory pressures. Investors should monitor earnings releases for signs of a sustained turnaround and watch the price action around the key resistance level near 31.8 AUD before committing to larger positions.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI approaching overbought levels
- Proximity to resistance at ~31.8 AUD
- Increasing volume supporting current trend
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward EPS turning positive
- Analyst median price target around 31 AUD
- Bullish technical setup with SMA alignment
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Potential earnings turnaround and cash‑flow improvement
- Diversified geographic footprint reducing single‑market exposure
- Modest dividend yield with low payout ratio offering upside if profitability stabilises
Key Metrics & Analysis
Financial Health
Revenue Growth3.50%
Profit Margin-0.76%
P/E Ratio15.8
ROE-2.23%
ROA-0.51%
Debt/Equity29.03
P/B Ratio2.3
Op. Cash FlowA$104.5M
Free Cash FlowA$-45325000
Technical Analysis
TrendBullish
RSI69.3
SupportA$23.05
ResistanceA$31.81
MA 20A$27.47
MA 50A$23.68
MA 200A$19.04
MACDBullish
VolumeIncreasing
Fear & Greed Index91.46
Valuation
Fair ValueA$2.70
Target PriceA$28.98
Upside/Downside-0.75%
GradeFair
TypeBlend
Dividend Yield0.92%
Risk Assessment
Beta0.77
Volatility32.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.